| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xencor, Inc. (XNCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. XNCR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 477.3K | $6.69M | - | |
| VP | 242.9K | $3.40M | - | |
| Dir | 110.4K | $1.55M | - | |
| CFO | 75.9K | $1.06M | - | |
| Dir | 15.5K | $217.8K | -5,064 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2016 | Dahiyat Bassil I74 | President And CEO | Sale+OE | 45,886 | $22.06 | $1,012,317.16 | -5.7% | |
| Aug 15, 2016 | Stafford John S III | 10% Owner | Sell | 10,000 | $23.06 | $230,550.00 | -0.2% | |
| Aug 15, 2016 | Carter Bruce L A | Director | Sale+OE | 3,400 | $22.67 | $77,074.03 | -20.0% | |
| Aug 11, 2016 | Stafford John S III | 10% Owner | Sell | 30,500 | $21.87 | $667,012.50 | -0.2% | |
| Aug 10, 2016 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 2,500 | $21.83 | $54,575.75 | -100% | |
| Aug 3, 2016 | Foster Paul A | Chief Medical Officer | Sale+OE | 5,000 | $20.01 | $100,050.00 | -67.4% | |
| Aug 3, 2016 | Desjarlais John R76 | Sr. V.p., Research &CSO | Sell | 5,905 | $20.00 | $118,100.00 | -11.6% | |
| Aug 3, 2016 | Baracchini Edgardo Jr | Chief Business Officer | Sell | 4,528 | $20.00 | $90,560.00 | -100% | |
| Jul 11, 2016 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 1,250 | $18.13 | $22,662.50 | -21.6% | |
| Jun 28, 2016 | Foster Paul A | Chief Medical Officer | Sell | 1,183 | $17.01 | $20,122.83 | -32.8% |